In addition, we performed immunohistochemistry and found that compared to the normal nasopharyngeal mucosa tissue, the number of CD56 + NK cells and the expression of granzyme B, one of the key cytotoxic effector of NK cell, were decreased in NK-NPC (Fig. 1F). The gene discussed is NCAM1; the disease is nasopharyngeal carcinoma.